197 related articles for article (PubMed ID: 25349217)
1. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.
Tian J; Wang Y; Liu X; Zhou X; Li R
Exp Biol Med (Maywood); 2015 Jul; 240(7):936-45. PubMed ID: 25349217
[TBL] [Abstract][Full Text] [Related]
2. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
Tian J; Wang Y; Guo H; Li R
Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin slows IgA nephropathy progression in the rat.
Tian J; Wang Y; Zhou X; Li Y; Wang C; Li J; Li R
Am J Nephrol; 2014; 39(3):218-29. PubMed ID: 24603476
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in a Rat Model of IgA Nephropathy.
Liu D; Liu Y; Chen G; He L; Tang C; Wang C; Yang D; Li H; Dong Z; Liu H
Am J Nephrol; 2017; 45(4):293-300. PubMed ID: 28237991
[TBL] [Abstract][Full Text] [Related]
5. The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy.
Guo N; Liu S; Bow LM; Cui X; Zhang L; Xu S; Lu S; Tian J
Ren Fail; 2019 Nov; 41(1):334-339. PubMed ID: 31057050
[TBL] [Abstract][Full Text] [Related]
6. Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression.
Chen H; Du Y; Li Y; Zeng J; Miao J; Jiang X
J Tradit Chin Med; 2019 Jun; 39(3):346-355. PubMed ID: 32186007
[TBL] [Abstract][Full Text] [Related]
7. The p70S6K/PI3K/MAPK feedback loop releases the inhibition effect of high-dose rapamycin on rat mesangial cell proliferation.
Tian J; Chang S; Ji H; Huang T; Guo H; Kang J; Wang Y; Zhou Y
Int J Immunopathol Pharmacol; 2021; 35():20587384211000544. PubMed ID: 34034560
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid inhibits mesangial cell proliferation by up-regulating p21Waf1/Cip1 and p27Kip1 and down-regulating Skp2.
Su B; Chen X; Zhong C; Guo N; He J; Fan Y
J Nephrol; 2012; 25(6):1031-40. PubMed ID: 22344541
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway.
Xia M; Liu D; Tang X; Liu Y; Liu H; Liu Y; Chen G; Liu H
Int Immunopharmacol; 2020 Mar; 80():106125. PubMed ID: 31931362
[TBL] [Abstract][Full Text] [Related]
10. A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2.
Liu S; Xie Y; Lv Y; Qin F; Fu B; Shi S; Yin Z; Hong Q; Zhang X; Wang J; Chang M; Chen X
Am J Nephrol; 2010; 32(5):447-55. PubMed ID: 20924167
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells.
Zou L; Wang W; Xu Z; Zhang N; Jiang T
Int J Mol Med; 2012 Aug; 30(2):409-16. PubMed ID: 22614447
[TBL] [Abstract][Full Text] [Related]
12. Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy.
Gan L; Li X; Zhu M; Chen C; Luo H; Zhou Q
Ren Fail; 2018 Nov; 40(1):364-370. PubMed ID: 29708439
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production.
Lock HR; Sacks SH; Robson MG
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F76-81. PubMed ID: 16896187
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine Hydrochloride Protects IgA Nephropathy Through Regulating Cell Growth and Apoptosis of T and B Lymphocytes.
Li JJ; Li L; Li S; Tang XY; Sun HF; Liu JX
Drug Des Devel Ther; 2024; 18():1247-1262. PubMed ID: 38645988
[TBL] [Abstract][Full Text] [Related]
15. The effect of FoxO1 on the proliferation of rat mesangial cells under high glucose conditions.
Liu F; Ma XJ; Wang QZ; Zhao YY; Wu LN; Qin GJ
Nephrol Dial Transplant; 2014 Oct; 29(10):1879-87. PubMed ID: 24914090
[TBL] [Abstract][Full Text] [Related]
16. Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy.
Qiu LQ; Sinniah R; Hsu SI
Lab Invest; 2004 Sep; 84(9):1112-25. PubMed ID: 15208647
[TBL] [Abstract][Full Text] [Related]
17. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
[TBL] [Abstract][Full Text] [Related]
18. Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression.
Jia H; Qi X; Fang S; Jin Y; Han X; Wang Y; Wang A; Zhou H
Regul Pept; 2009 Apr; 154(1-3):69-76. PubMed ID: 19154760
[TBL] [Abstract][Full Text] [Related]
19. Expression of USP2-69 in mesangial cells in vivo and in vitro.
Wang S; Wu H; Liu Y; Sun J; Zhao Z; Chen Q; Guo M; Ma D; Zhang Z
Pathol Int; 2010 Mar; 60(3):184-92. PubMed ID: 20403044
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
